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Dosage compensation of the chicken Z chromosome <p>Microarray data analysis revealed a cluster of well compensated genes in the MHM (male-hypermethylated) region on chicken chro- mosome Zp, whereas Zq is enriched in non-compensated genes.  The non-coding MHM RNA may therefore play a role in dosage compen- sation in the female.</p>
Abstract
Background: Most Z chromosome genes in birds are expressed at a higher level in ZZ males than
in ZW females, and thus are relatively ineffectively dosage compensated. Some Z genes are
compensated, however, by an unknown mechanism. Previous studies identified a non-coding RNA
in the male hypermethylated (MHM) region, associated with sex-specific histone acetylation, which
has been proposed to be involved in dosage compensation.
Results: Using microarray mRNA expression analysis, we find that dosage compensated and non-
compensated genes occur across the Z chromosome, but a cluster of compensated genes are
found in the MHM region of chicken chromosome Zp, whereas Zq is enriched in non-compensated
genes. The degree of dosage compensation among Z genes is predicted better by the level of
expression of Z genes in males than in females, probably because of better compensation of genes
with lower levels of expression. Compensated genes have different functional properties than non-
compensated genes, suggesting that dosage compensation has evolved gene-by-gene according to
selective pressures on each gene. The group of genes comprising the MHM region also resides on
a primitive mammalian (platypus) sex chromosome and, thus, may represent an ancestral precursor
to avian ZZ/ZW and monotreme XX/XY sex chromosome systems.
Conclusion: The aggregation of dosage compensated genes near the MHM locus may reflect a
local sex- and chromosome-specific mechanism of dosage compensation, perhaps mediated by the
MHM non-coding RNA.
Background
In birds, males are homogametic (ZZ) and females are heter-
o g a m e t i c  ( Z W ) ,  i n  c o n t r a s t  to the mammalian pattern of
female XX homogamety and male XY heterogamety. Like the
mammalian X and Y chromosomes, the euchromatic Z is
large (over 500 genes) and the heterochromatic W small
(probably containing tens of genes) [1-4]. In both groups, the
difference in copy number of the Z or X chromosomes results
in one sex having a higher genomic dose of Z or X genes.
Gene dosage is considered to be critical, at least for a signifi-
cant number of genes, and an imbalance in chromosomal
number (aneuploidy) can result in conditions such as Turner
syndrome (XO), Klinefelter syndrome (XXY), Down
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syndrome (Trisomy 21), and cancer [5-7]. Aneuploidy for an
entire chromosome is usually lethal [8]. Because a delicate
balance in gene dosage is important for proper functioning
and organismal survival, numerous species have evolved
mechanisms of sex chromosome dosage compensation,
which balances the expressed dose of X genes between males
and females, and between the X chromosome and the auto-
somes. Mammalian dosage compensation is accomplished
through inactivation of one of the X chromosomes in every
female cell, and upregulation of the single active X chromo-
some in both males and females [9,10]. These combined
mechanisms effectively equate the expressed gene dose
between the X chromosome and autosomes [9,11]. Other XX-
XY species have evolved different effective dosage compensa-
tion mechanisms. For example, Drosophila XY males upreg-
ulate gene expression from their single X chromosome to
bring the dose on par with that of the XX female and with
autosomes [12,13]. In Caenorhabditis elegans, XO males and
XX hermaphrodites both upregulate X gene expression and
the hermaphrodite downregulates each X chromosome, again
resulting in compensation of X genes between the sexes and
with autosomes [8,12].
In birds, however, Z genes are not as well compensated as are
X genes in mammals, flies, and worms [11,14-19]. Z mRNAs
are expressed about 30-40% higher in chicken ZZ males than
in ZW females [11]. In addition, several Z genes appear to be
expressed biallelically, suggesting that inactivation of an
entire Z chromosome does not occur in males [20,21]. Never-
theless, an unknown type of dosage compensation mecha-
nism results in sexual parity of expression for some Z
chromosome genes, bringing the Z to autosomal ratio of
expression to around 0.8 in ZW female chickens [11,15].
The mechanism of dosage compensation on the Z chromo-
some is unclear. In chickens a female specific non-coding
RNA is expressed from the male hypermethylated (MHM)
locus and accumulates near its transcription site on the Z
chromosome [22]. In ZZ males, the DNA at the MHM locus
remains hypermethylated and untranscribed [22]. In addi-
tion, histone H4 at lysine residue 16 is acetylated in a region
surrounding the MHM locus in ZW females but not in ZZ
males [23]. Other non-coding RNAs, such as XIST in mam-
mals and roX genes in Drosophila, are implicated in the con-
trol of X chromosome dosage compensation. Moreover,
histone H4 acetylation is associated with dosage compensa-
tion in Drosophila [24]. These observations suggest that the
MHM RNA and female-specific histone acetylation may lead
to hypertranscription of Z genes in females, which could com-
pensate Z dosage [23]. It is not clear, however, whether a dos-
age compensation mechanism occurs in only one or in both
sexes, and which parts of the Z chromosome might be
affected. The involvement of MHM and its associated histone
acetylation in dosage compensation has, heretofore, received
no direct support.
By mapping the male to female ratios of mRNA expression of
Z genes according to their positions on the Z chromosome, we
report here that dosage compensated genes are located all
along the chromosome, but that the MHM region contains a
higher percentage of compensated genes than other regions.
Compensated genes show signs of having significantly differ-
ent functional properties than genes that are not compen-
sated, suggesting that dosage compensation has evolved
according to selective pressures on individual genes. We pro-
pose that detrimental effects of a lack of overall dosage com-
pensation on the Z chromosome may be mitigated by
selective compensation of genes that are most dosage-critical,
both in the MHM region and elsewhere on the Z
chromosome.
Results
Regional variation of dosage compensation
We measured mRNA expression in brain, heart, and liver of
male and female chick embryos at 14 days of incubation,
based on microarray analysis (see [11]). In each tissue, the
male:female (M:F) ratio of mRNA expression was calculated
for each gene. We have previously reported that Z genes are
expressed at higher M:F ratios than autosomal genes, and
that some Z genes appear to be dosage compensated (M:F
ratios in the range 0.8-1.3, for example) whereas many others
are not (for example, ratios above 1.5) [11]. To determine
whether genes showing dosage compensation are concen-
trated in specific regions of the Z chromosome, we mapped
M:F ratio by gene position along the Z chromosome (Figure
1a). The map indicates that genes with high and low M:F
ratios are found across the entire Z chromosome. To accentu-
ate trends in the amount of dosage compensation, we com-
puted a running average of M:F ratios as a function of
position on the Z chromosome (Figure 1b). We observed two
major features in the running average curve: a dip ('valley')
and a broad peak corresponding to areas rich in compensated
and non-compensated genes, respectively. These features
were independent of the number of genes averaged to smooth
the curve. The valley was not produced by a small number of
genes with exceptionally low M:F ratios, but rather was
formed because of the relative lack of genes with high M:F
ratios in all three tissues (for example, Figure 1a). The peak
resulted from an over-representation of high M:F ratios. The
valley was located on Zp near the centromere and overlapped
with the MHM locus (NCBI CoreNucleotide accession
number AB046699), whereas the peak was found on the dis-
tal end of Zq. The graphs for three tissues showed highly sim-
ilar peaks and valleys (Figure 1b-d), suggesting that
regulation of M:F ratios occurs globally, perhaps by a regional
mechanism on the Z chromosome, and not just by tissue-spe-
cific factors. The approximate boundaries of the Zp MHM val-
ley (2.5E7 to 3.5E7 bp) and Zq peak (5.5E7 to 7.5E7 bp) were
estimated visually based on common inflection points in the
three curves (Figure 1b-d). In the datasets of genes expressed
in brain, heart, or liver, valley genes accounted for 61 andhttp://genomebiology.com/2007/8/9/R202 Genome Biology 2007,     Volume 8, Issue 9, Article R202       Melamed and Arnold  R202.3
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M:F ratios as a function of Z chromosome position for brain, heart, and liver tissues Figure 1
M:F ratios as a function of Z chromosome position for brain, heart, and liver tissues. (a) Individual M:F ratios in the brain, graphed by gene position on the 
Z chromosome. (b-d) The running average of 30 M:F ratios is plotted at the median gene position, for brain, heart, and liver. The curves all show a dip, or 
valley, surrounding the MHM locus of Zp, comprising a cluster of dosage compensated genes in a region deficient in genes with high M:F ratios, as well as 
an elevated region (one or two peaks) at the distal end of Zq with an unusual concentration of non-compensated genes.
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peak genes for 121 of 504 expressed Z genes (Additional data
file 1). The mean M:F ratio for Zp genes was significantly
lower than the mean M:F ratio for Zq genes in the three tis-
sues (p < 0.004 for brain, p < 0.00083 for heart, and p <
0.045 for liver, t-test).
To test whether the peaks and valleys of the three curves
occur by chance, for each tissue we counted the number of
consecutive positions on the graphs in Figure 1b-d that
remain below the 40th percentile of Z M:F ratios in the Zp val-
ley, or remain above the 60th percentile of Z M:F ratios in the
Zq peak. Then we shuffled the M:F ratios of genes randomly
10,000 times for each tissue and found that consecutive runs
of low valley values and high peak values occurred rarely
together on each shuffled chromosome in the permutation
analysis (p  < 0.0001 in each tissue). The valley occurred
rarely (p ≤ 0.001) by chance within 30 positions of the MHM
locus (p < 0.004) or indeed anywhere on the chromosome (p
≤ 0.001) in each tissue.
To determine whether the valley and peaks were unique to the
Z chromosome, we calculated the running averages of M:F
ratios for 18 autosomes with at least 200 expressed genes
each. In contrast with the Z chromosome, autosomal gene
M:F ratios were similar to each other, with means near 1, but
with no peaks or valleys comparable to those on the Z chro-
mosome (Figure 2).
Non-linear measurement of expression by microarrays could
theoretically lead to underestimates of M:F ratios in regions
of the chromosome that contain genes with low or high levels
of expression. We previously used quantitative PCR to con-
firm M:F ratio accuracy in the microarray dataset [11]. To test
whether the unusual cluster of dosage compensated genes in
the MHM valley could result from low gene expression levels,
we compared gene expression levels across the Z chromo-
some and on chromosome 1 (Additional data file 6). We found
that other regions of the Z chromosome have equal or lower
average expression levels, and that the MHM valley and Zq
peak are not well predicted by the level of expression of genes.
Moreover, Z expression levels were comparable to those on
autosomes, where M:F ratios are near 1. Thus, the regional
variation in M:F ratios appear not to be an artifact of regional
differences in expression levels.
Correlation of compensation with sex-specific gene 
expression
We examined variation in expression levels of Z genes in the
two sexes for evidence of gene regulation that might reflect a
sex-specific mechanism of dosage compensation. In ZW
Running average of M:F ratios on the Z chromosome and autosomes Figure 2
Running average of M:F ratios on the Z chromosome and autosomes. Top: 
plot of the M:F ratio of individual Z genes in brain (black) compared with 
the expression genes for 18 autosomes (red) containing more than 200 
genes. Bottom: the running average of M:F ratios (calculated as in Figure 1) 
for brain shows that the Z chromosome (black) has much more 
pronounced valleys and peaks than are found in the autosomes (red 
through blue).
Table 1
Expression levels in males and females of all Z genes and compensated and non-compensated Z genes
All Z genes Compensated Z genes Non-compensated Z genes
Male brain 228 ± 12 179 ± 15 295 ± 23
Female brain 162 ± 8 161 ± 13 169 ± 14
Male liver 366 ± 30 263 ± 32 596 ± 78
Female liver 287 ± 24 248 ± 30 363 ± 48
Male heart 388 ± 24 317 ± 33 567 ± 49
Female heart 280 ± 18 283 ± 28 332 ± 29
Data are mean ± standard error of the mean. Compensated genes are those with an M:F ratio below 1.3; not compensated genes are those with an 
M:F ratio above 1.5.http://genomebiology.com/2007/8/9/R202 Genome Biology 2007,     Volume 8, Issue 9, Article R202       Melamed and Arnold  R202.5
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females, the average level of expression of dosage compen-
sated and non-compensated genes was about equal to the
average for the entire Z chromosome, but in ZZ males com-
pensated genes were expressed on average at a lower level,
and non-compensated genes at a higher level, than the Z
chromosome average (Table 1, Figures 3 and 4). Bootstrap
resampling analysis indicated that the female expression val-
ues for compensated and non-compensated genes did not dif-
fer significantly from all Z genes (p  > 0.05), whereas the
actual mean male expression values for compensated and
non-compensated genes in each tissue were unexpected if the
genes were drawn at random from the set of all Z genes (p <
0.02 in each case).
The level of expression of Z genes in each tissue in males was
significantly positively correlated with the M:F ratio of Z
genes (Pearson correlation coefficient r = 0.192 to 0.234, p <
0.0011) whereas the female expression values were not signif-
icantly correlated with M:F ratios (r = 0.013 to 0.075, p > 0.1)
(Figure 4). A priori, it is not clear whether the positive corre-
lation in the male is the result of the dosage compensation or
results from another mechanism. To determine if these corre-
lation patterns might suggest which sex possesses a compen-
sation mechanism to adjust the dose of some Z genes, we
modeled the effect of male-specific or female-specific com-
pensation mechanisms on the correlation of gene expression
with M:F ratio. In model I, the probability of dosage compen-
sation was assumed to be unrelated to the level of expression
of genes. Taking the brain gene expression values of chromo-
some 1 genes as a representative set of chicken genes, we
assigned to each chromosome 1 gene an M:F ratio drawn at
random from the distribution of Z chromosome M:F ratios.
To mimic a female-specific dosage compensation mecha-
nism, a Z M:F ratio was randomly assigned to each chromo-
some 1 male gene expression value. The assigned M:F ratio
and the male expression value was used to calculate the cor-
responding female expression value for the gene. In this
analysis, the female gene expression values reflected the level
of compensation normally found on the Z chromosome. To
model a male-specific compensation mechanism, a Z M:F
ratio was assigned randomly to each chromosome 1 female
gene and used to calculate the corresponding male expression
level. In each case, the assignment of M:F ratios to genes of
various expression levels was repeated 100 times, and in each
iteration the correlation coefficient r was calculated between
male expression values and M:F ratios, and female expression
values and M:F ratios.
When a female compensation mechanism was modeled, M:F
ratios were weakly negatively correlated with female expres-
sion (mean r = -0.21) and not correlated with male expression
(mean r = 0.00). When a male compensation mechanism was
modeled, M:F ratios were weakly positively correlated with
male expression (mean r = 0.20) and uncorrelated with
female expression (mean r = 0.00). Therefore, model 1 best
matched the observed correlation pattern between M:F ratios
and expression values on the Z chromosome when the male
but not female possessed a sex-specific mechanism of dosage
compensation. A male-specific mechanism means that the
male down-regulates expression of some genes to match the
level of expression in females (Figure 5). This mechanism, by
itself, could lower average Z gene expression levels below that
of autosomal genes, which conflicts with the observed Z:A
expression ratio of about 1 in males [11]. Thus, the assump-
tions leading to model I are questionable.
In model II, the amount of compensation was assumed to
increase as a function of gene expression level in both sexes
(since the level of expression of individual genes in the two
sexes is highly correlated across a wide range of gene expres-
sion values; Figure 4). The procedures for model II are equiv-
alent to those for model I except that M:F ratios were assigned
randomly to genes but then multiplied by an adjustment fac-
ZZ male and ZW female expression levels as a function of M:F ratio Figure 3
ZZ male and ZW female expression levels as a function of M:F ratio. 
Graphs show the median expression level of genes as a function of M:F 
ratio. For each tissue, all genes showing expression from the Z 
chromosome or from autosomes 1-5 were grouped into bins according to 
M:F ratio. The graphs indicate that autosomal genes with high (>1.2) or 
low (<0.8) M:F ratios show generally lower expression, in both sexes, 
relative to genes that are equally expressed in the two sexes (M:F ratio 
near 1), indicating that sexually dimorphic expression is not associated 
with higher expression in one sex relative to the majority of genes. Among 
Z genes, expression in females varies little as M:F ratio changes. Male 
genes, however, are expressed significantly lower at low M:F ratios near 1, 
relative to higher M:F ratios. Bin width is 0.2. Values are plotted at the 
mid-point of the bin. A small number of genes, with M:F ratios outside of 
the range shown, are included in the most extreme bins.R202.6 Genome Biology 2007,     Volume 8, Issue 9, Article R202       Melamed and Arnold  http://genomebiology.com/2007/8/9/R202
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tor that incremented the M:F ratio in proportion to gene
expression level. The adjustment factor set M:F ratios about
20% higher for genes at the highest expression levels relative
to those at the lowest expression levels, with graded adjust-
ment in between. When a female compensation mechanism
was modeled, the M:F ratio correlated with male expression
level (mean r = 0.22) but not with female expression level
(mean r = -0.02). When a male compensation mechanism
was modeled, M:F ratio was correlated with both male (mean
r = 0.41) and female (mean r = 0.22) expression level. Thus,
under this set of assumptions, a female compensation mech-
anism led to a correlation pattern most similar to the
observed pattern.
Functional differences among compensated versus 
non-compensated genes
We used two different algorithms to explore the functional
characteristics of genes in different regions of the Z chromo-
some: Database for Annotation, Visualization and Integrated
Discovery (DAVID) and Ingenuity Pathway Analysis (IPA).
We first asked whether genes in the valley and peaks on the Z
chromosome were enriched in specific functions (Additional
data files 2 and 3). Valley genes were found to be enriched in
genes involved in regulation of cellular physiological process,
regulation of DNA dependent transcription, reproductive sys-
tem development and function, embryonic development,
developmental disorder, and cellular growth and prolifera-
tion. Peak genes were enriched for involvement in the
nucleus, DNA repair and response to DNA damage, catalytic
activity, and intracellular membrane bound organelle (Addi-
tional data files 2 and 3).
We also asked whether compensated and non-compensated
genes, irrespective of their position on the Z chromosome,
differed in gene functions (Additional data files 4 and 5).
Compensated and non-compensated genes were arbitrarily
defined as genes with M:F ratios less than 1.3 or higher than
1.5, respectively. Compensated genes were enriched in all
three tissues for cell signaling and interaction, developmental
disorder, organismal development/survival, cellular growth
and proliferation, signal transducer activity in heart and
brain, and receptor activity in brain. Non-compensated genes
were enriched for intracellular membrane bound organelle in
all three tissues, and for intracellular, chromosome, cell
organization and biogenesis, and nucleus in brain (Additional
data files 4 and 5).
Discussion
Here we report that dosage compensated genes are inter-
spersed with non-compensated genes across the entire Z
chromosome of chickens. Nevertheless, a higher concentra-
tion of fully compensated genes occurs in a region adjacent to
the MHM locus, which shows female-specific expression of
the non-coding MHM RNA [22]. The same region is enriched
in female-specific hyperacetylation of histone H4, which is
postulated to play a role in balancing gene expression
between the sexes [23]. The clear regional correlation of dos-
age compensation with female-specific RNA expression and
chromatin modifications suggests strongly that the MHM
non-coding RNA and/or associated histone modifications are
involved in regulating dosage compensation of Z genes. The
pattern suggests that compensation in the MHM valley is reg-
ulated by a chromosome-specific mechanism, as is found for
sex chromosomes of other species, rather than by a gene-spe-
cific or tissue-specific molecular mechanism. The aggregation
of dosage compensated genes in the MHM valley may be bio-
logically meaningful because it is unlikely to have occurred by
chance. In contrast to mammals, Drosophila, and C. elegans,
in which sex chromosome dosage compensation is chromo-
some-wide, chicken dosage compensation appears to occur in
a greater percentage of genes in a relatively small region of
Zp, suggesting that the DNA in this region is specialized. It is
intriguing that a general sex-specific and multi-genic molecu-
Relationship between male and female gene expression and M:F ratio in brain Figure 4
Relationship between male and female gene expression and M:F ratio in brain. The level of expression of each gene in brain is plotted as a function of M:F 
ratio for each sex, to illustrate the correlation of the two variables in males but not females.
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lar mechanism of dosage compensation might exist in birds,
but not have spread to all regions of the sex chromosome as
occurs in various XX-XY systems. Of course, if the MHM RNA
is centrally involved in Z dosage compensation, its effects may
also occur beyond the MHM valley, and contribute to com-
pensation of specific genes in other Z regions. The concentra-
tion of dosage compensation in the MHM valley, compared
with chromosome-wide mechanisms in other species, raises
the question of what evolutionary forces account for these dif-
ferences in dosage compensation mechanisms in various
taxa.
Several findings suggest that the mechanism of dosage com-
pensation might be initiated in the ZW female. The MHM
RNA is expressed only in females, and is spatially associated
with restricted female-specific acetylation of histone H4
[22,23]. Moreover, MHM RNA expression is found in ZW
diploid and ZZW triploid chickens, but not in ZZ diploid and
ZZZ triploid chickens, which led Teranishi et al. [22] to sug-
gest that MHM expression requires the presence of the W
chromosome. However, in those studies the presence of the
W chromosome was confounded with the Z:A ratio (Z:A ratio
of 1 in birds without a W chromosome, and less than 1 for
those with a W chromosome), so that it is unclear whether the
MHM RNA is activated by the W chromosome in females or
inactivated (for example, hypermethylated) based on Z:A
ratio in males. Here we find that the M:F ratio of Z genes is
correlated better with male expression levels than with
female expression levels. Assuming that dosage compensa-
tion is equally likely for Z genes with different levels of expres-
sion (model I), this pattern suggests that males possess a
compensation mechanism. If males reduce gene expression
to match that of the female for some Z genes, however, the
male Z:A ratio might be expected to be below 1, which is not
observed [11]. Thus, model I appears unlikely. Model I would
fit a scenario, however, in which the expression of Z genes is
increased in both sexes, relative to autosomal genes. An
i n c r e a s e  i n  Z  g e n e  e x p r e s s i o n  c o u l d  r e s u l t  f r o m  s e l e c t i o n
pressure in the ZW female in response to gene loss from the
W chromosome and differentiation from the Z. Such an effect
would have increased the Z:A ratio in males to above 1, and
reduced the disparity in expression of Z and A genes in
females. At the same time, however, a male-specific reduction
in gene expression, restricted to a subset of Z genes, could
then have reduced the overall male Z:A ratio to near 1, as we
observe in the chicken.
The alternative model II also accounts for the observed pat-
tern of results, if genes selected for dosage compensation
have lower average levels of expression than those that are
not compensated. That selection makes the male expression
level correlate with M:F ratio, and a female-specific
compensatory mechanism increases expression of the com-
pensated genes in females to the level of males. The increase
in expression of the genes with lower expression levels has the
effect of abolishing a positive correlation of M:F ratio with
expression level in females (Figure 5). The present data,
therefore, are compatible with previous studies suggesting
Models of sex-specific mechanisms of dosage compensation Figure 5
Models of sex-specific mechanisms of dosage compensation. Model 1 assumes that prior to compensation, female (red line) and male (dotted black line) 
expression is unrelated to the eventual amount of dosage compensation. If the male reduces expression of genes to compensate, the line tilts down on the 
left, resulting in a pattern of positive correlation of level of expression and M:F ratio (black solid line), close to that observed. Model II assumes that prior 
to dosage compensation, female (red dotted line) and male (black solid line) expression is correlated with the eventual level of compensation (lower 
average expression in genes to be compensated). In model II, female-specific compensation, illustrated by the shift to the red solid line in the female, leads 
to the observed pattern in which female expression does not correlate with M:F ratio. Arrows indicate shifts required in each model to achieve the 
observed pattern that male gene expression is correlated with M:F ratio, but female level of expression is not.
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that dosage compensation occurs in females, but is applied
more frequently to genes with lower expression values. A
male-specific mechanism of dosage compensation is not
ruled out, however, and further work is needed to resolve the
mechanisms of dosage compensation.
Dosage tolerance and the evolutionary pressure for dosage
compensation of Z genes must certainly be related to gene
function. Despite the currently incomplete annotation of
genes especially in birds, our analysis of Z gene functions is
compatible with the idea that compensated and non-compen-
sated genes (or chromosomal regions) are involved in differ-
ent cellular functions. Genes in the MHM valley were
enriched in regulation and developmental functions, whereas
genes in the Zq peaks were enriched in catalytic activity and
intracellular organelle involvement. Compensated genes on
the Z chromosome were enriched in extracellular membrane
associated functions like signal transduction and protein
binding, compared to intracellular organelle associated func-
tions for non-compensated Z chromosome genes. One inter-
pretation of these findings is that compensated valley and
non-valley genes regulate other genes (for example, during
development) and, therefore, may be especially sensitive to
dosage effects because changes in their dose might propagate
through numerous downstream gene networks. In contrast,
genes in the peaks and other non-compensated genes partic-
ipating in intraceulular housekeeping and catalytic activities
may be less sensitive to effects of dose. For example, the func-
tion of synthetic pathways is not sensitive to the copy number
of enzyme genes comprising the pathways [25]. Also, hetero-
zygotes for various traits and metabolic mutations are similar
in phenotype to normal homozygotes [25,26]. The presence
of many cellular checkpoints in the form of end-product inhi-
bition that control enzyme levels may thus preclude a fine
control of such genes at the transcription level [27].
Another factor that might influence the clustering of dosage
compensation in the MHM valley is the evolutionary history
of this segment. The sex chromosomes of birds and
monotremes may have common origins, since the X chromo-
some of the platypus contains genes in common with the Z
chromosome of birds [28,29]. Indeed, homologues of 65% of
MHM valley genes and 27% of peak genes are found on the
platypus sex chromosome X5, and, therefore, may represent
remnants of an ancient precursor to both the monotreme and
avian sex chromosomes. The shared evolutionary history of
MHM genes on avian and primitive mammalian sex chromo-
somes raises the question whether genes homologous to the
MHM valley are exceptionally well dosage compensated
among X genes in monotremes. If so, the evolution of an
MHM-specific mechanism of dosage compensation may be
ancestral to both birds and monotremes.
How might the MHM valley have accumulated an unusually
high concentration of dosage compensated genes? One sce-
nario is that the MHM valley represents the location at which
the original sex-determining mutation occurred in birds, pro-
ducing the proto-W chromosome that was differentiated from
the corresponding region of the proto-Z chromosome over a
small region [1]. The loss of recombination between the
proto-Z and proto-W at this location would have brought the
newly hemizygous segment of the Z chromosome under sex-
specific selection pressure to compensate Z gene dose. There-
fore, the MHM region of the Z chromosome would have been
subject to dosage-compensated pressure longer than the rest
of the Z chromosome [2,30]. The mammalian X chromosome
has similarly been molded by evolutionary forces that pro-
duced X strata with different properties depending on time
since the divergence of that segment on the X and Y chromo-
some [30,31]. The oldest stratum shows more complete X-
inactivation and contains SOX3, the nearest X homologue of
the Y-linked testis-determining gene SRY  [1,30-37]. If the
MHM valley represents the oldest part of the Z chromosome,
then it might also harbor the site of the original avian W
female-determining mutation. It is particularly intriguing,
therefore, that the MHM valley includes DMRT1 [22], the tes-
tis development gene that, if mutated on the W, could have
led to DMRT1 haploinsufficiency for testis development in
ancestral ZW birds [38]. Although this speculation is seduc-
tive because it lends weight to the idea that DMRT1 is the sex-
determining gene, it conflicts with the report that the oldest
stratum of chicken Z chromosome is Zq, not Zp where MHM
is located [39,40]. One possible resolution of this paradox is
that the accurate identification of strata on the chicken Z
chromosome may require a comparison of a larger set of Z
and W gene sequences than has been available to date, and
that the MHM valley is indeed a segment of the oldest stratum
that has been translocated to a group of more recently added
Zp genes. Alternatively, if the MHM valley is actually a part of
a newer segment of the Z, the present results would argue that
factors other than time since Z-W divergence may dominate
in the evolution of dosage compensation.
Conclusion
The present results, together with previous studies, show that
gene distribution on the Z chromosome is non-random, and
that dosage compensated genes occur at higher density in the
MHM valley. We propose that compensated genes are the
most sensitive to differences in copy number, and that selec-
tive compensation of those genes avoids the serious detri-
mental effects normally associated with aneuploidy. The
selectivity of the dosage compensation mechanism may also
be reflected in the finding that non-compensated genes have
higher average levels of expression than compensated genes
in males. The current results are compatible with a female-
specific mechanism of dosage compensation of selected
genes.http://genomebiology.com/2007/8/9/R202 Genome Biology 2007,     Volume 8, Issue 9, Article R202       Melamed and Arnold  R202.9
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Materials and methods
Animals, tissues and microarrays
The preparation of RNA from chicken tissues and microarray
data analysis have been described previously [11]. Briefly,
brain, heart, and liver tissues were harvested from 20 male
and 20 female white leghorn chicken embryos at 14 days of
incubation. RNA samples were combined into three to four
animals per pool, five pools per sex, and hybridized to
Affymetrix Chicken Arrays. The microarray contained probes
for over 28,000 chicken genes. Data normalization and filtra-
tion were performed in DChip software [11]. To decrease gene
redundancy, Affymetrix IDs were combined if they mapped to
the same EntrezGeneID. The final dataset of probe sets con-
sisted of 9,692 for brain (465 Z, 9,227 autosomal), 8,737 for
liver (415 Z, 8,322 autosomal), and 9,119 for heart (444 Z,
8,675 autosomal). Array data are available from Gene Expres-
sion Omnibus [41] (accession numbers GSE6843, GSE6844,
GSE6856). Gene positions on the Z chromosome were based
on release 2.1 of the chicken genome [42].
Expression data analysis
Statistical analyses were performed in the statistical environ-
ment R 2.0.1 using packages from R and Bioconductor
projects [43]. The distribution of M:F ratios on the Z chromo-
some was analyzed using the gtools R-based package, which
computed the running average of M:F ratios with a mean
length of 30 genes.
To calculate whether the distribution of M:F ratios along the
Z chromosome was random, we calculated: Clow, the number
of consecutive positions of the running average curves in Fig-
ures 1b-d that stayed below the 40th percentile of Z gene M:F
ratios; and Chigh, the number of consecutive positions that
stayed above the 60th percentile. For example, in brain the
curve remained below the 40th percentile for 30 gene posi-
tions in the valley, and above the 60th percentile for 46 posi-
tions on Zq. We then shuffled the M:F ratios of Z genes
randomly, calculating Clow and Chigh each time (using Resam-
pling Stats [44]), to determine the probability that the two
runs of values occurred on the same shuffled chromosome. In
each tissue (Figures 1b-d), the observed runs of values
occurred at p < 0.0001.
To compare the level of expression of Z genes in each sex to
M:F ratios, we calculated Pearson correlation coefficients (r)
between male expression values and the ratios, and female
expression values and the ratios, for each tissue. To remove a
small number of outliers that have a disproportionate effect
on these correlations, we eliminated less than 5% of genes
from each tissue for which the male or female expression val-
ues differed from the mean by more than 2 standard devia-
tions. Outliers were similarly removed for the calculations in
Table 1 but not for the calculations of medians in Figure 3 or
the data of Figure 4 and Additional data file 6. We used boot-
strap methods [44] to resample with replacement male (or
female) expression values on Z chromosomes to determine
the probability of finding the mean expression values for
compensated or non-compensated genes shown in Table 1.
Analysis of gene functions and orthologs
We used the DAVID 2.0 and IPA (version 3.0; Ingenuity Sys-
tems, Mountain View, CA, USA) [45,46] to identify functional
enrichment of different groups of Z chromosome genes.
DAVID is a web-based application that allows users to query
a database of functional annotations and determine gene
enrichment in annotation terms based on Fisher's exact test.
We used default parameters in the Chart feature for each data
set with highest Gene Ontology term for maximal annotation
coverage. Pathway analysis was performed using IPA, which
identified most significant biological functions and/or dis-
eases in our datasets. IPA is based on a large number of man-
ually collected relationships between genes from the scientific
literature. Gene enrichment was calculated by a right tailed
Fisher's exact test. Because IPA is based on mammalian
genomes, we converted chicken Z genes to orthologous
human genes using data from the Ensembl database version
42 [42].
Gene and population lists were compiled in R and uploaded
into DAVID and IPA. Gene lists consisted of compensated,
non-compensated, valley, peak, or all Z chromosome genes.
Compensated genes were defined as genes with an M:F ratio
of less than 1.3 in one tissue, and non-compensated genes
were defined as genes with an M:F ratio of greater than 1.5 in
one tissue. Genes in the MHM valley were included if they
were between 2.5E7 bp and 3.5E7 bp (assembly:WASHUC2).
Peak genes were included in the analysis if they were between
5.5E7 and 7.5E7 bp.
Abbreviations
DAVID, Database for Annotation, Visualization and Inte-
grated Discovery; IPA, Ingenuity Pathway Analysis; M:F,
male:female; MHM, male-hypermethylated
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a table listing
valley and peak genes expressed in brain, heart, or liver tis-
sues. Additional data file 2 is a table listing gene categories
enriched among valley and peak genes using DAVID. Addi-
tional data file 3 is a table listing gene categories enriched
among valley and peak genes using IPA. Additional data file 4
is a table listing Gene categories enriched among compen-R202.10 Genome Biology 2007,     Volume 8, Issue 9, Article R202       Melamed and Arnold  http://genomebiology.com/2007/8/9/R202
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sated and non-compensated genes using DAVID. Additional
data file 5 is a table listing gene categories enriched among
compensated and non-compensated genes using IPA. Addi-
tional data file 6 is a figure relating gene expression levels to
M:F ratio as a function of Z or Chr1 position.
Additional data file 1 Valley and peak genes expressed in brain, heart, or liver tissues Valley and peak genes expressed in brain, heart, or liver tissues. Click here for file Additional data file 2 Gene categories enriched among valley and peak genes using  DAVID Gene categories enriched among valley and peak genes using  DAVID. Click here for file Additional data file 3 Gene categories enriched among valley and peak genes using IPA Gene categories enriched among valley and peak genes using IPA. Click here for file Additional data file 4 Gene categories enriched among compensated and non-compen- sated genes using DAVID Gene categories enriched among compensated and non-compen- sated genes using DAVID. Click here for file Additional data file 5 Gene categories enriched among compensated and non-compen- sated genes using IPA Gene categories enriched among compensated and non-compen- sated genes using IPA. Click here for file Additional data file 6 Gene expression levels related to M:F ratio and chromosome  position (a) Brain gene expression levels on the Z chromosome. Top:  expression level of individual genes is plotted by gene position for  males and females. Middle: the running average of 30 M:F ratios is  plotted according to median gene position. Bottom: the running  average of expression level of 30 genes is plotted relative to median  gene position. The MHM valley and Zq peak are not characterized  by unusually high or low expression values. A similar conclusion  emerges from analyses of gene expression in heart and liver, and  from analyses in which a small percentage of genes with very high  expression values are removed so as to limit their disproportionate  effect on running averages (data not shown). (b) Above: the run- ning average of 30 brain M:F ratios from chromosome 1, plotted  relative to median gene position. Below: the running average brain  expression values for 30 genes in males and females. M:F ratios are  quite different for chromosomes 1 and Z, even though the levels of  gene expression were similar (for example, in male brain Z gene  expression ranged from 14-6,334 (mean 335) versus 11-6,451  (mean 324) for chromosome 1). Click here for file
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